Quarterly Report on Laboratory Performance

Laboratory:
Quarter / Year of reporting
Microbiologists:
Contact Phone Number:
Workload and DST results – Report SPECIMENS processed on culture or DST,
DSTNOT PATIENTS
workload and res
Annexure IV of PMDT guidelines 2012 [DST results summary
Diagnostic
Sputum Solid first Liquid first
Follow-Up SPECIMENS inoculated (Solid &
Month SPECIMENS line DST line DST
Liquid)
inoculated (Solid & Processed Processed
Liquid)

Jan
Feb
Mar
Total
Performance indicators
Numerator (No.)
(1) Specimens (all) received within 7 days of sputum collection (with CPC)
(2)Specimens (all) received within 72 hours of sputum collection in 4-8 C
(without CPC*)
(3) Number of specimen rejected at the lab due to various reason(eg.
Leakage, inadequate quantity,
(4) Specimens (all) with culturesetc)
reported as Mtb. complex
(5) Smear-positive diagnostic specimens reported as culture-positive
(6) Specimen smear negative specimen reported as culture positive

(7) Specimens (all) with culture-contaminated results (by solid culture )

(8) Specimens (all) with culture-contaminated results (by liquid culture )
(9) Specimens (all) with culture results reported as NTM
(10) Patients (with diagnostic specimens) with DST completed within the
benchmark
(11) Patientsturn-around time (by
(with diagnostic Solid Culture)
specimens) with DST completed within the
benchmark turn-around time (by liquid Culture)
(12) Patients (with diagnostic specimens) with DST completed within the
benchmark
(13) Patientsturn-around time
(all) with final (by LPA
culture )
results reported to providers within 1 days
of declaration of result
(14) Patients with final DST results reported to providers within 1 days of
declaration
(15)Numberofand result
Percentage of invalid LPA results
(16) Number of events of LPA contamination in the quarter
(17) Number of EPTB sample reported as culture positive
(18) Most recent DST panel test performance Sensitivity (%)
H:
(Report Date _______________) R:
E (opt):
(Reference lab______________) S (opt):
(19) Most recent On-Site Evaluation Date:
Ref. Laboratory:
Evaluator:
atory Performance

DST,
DSTNOT PATIENTS
workload and results (from DST register)
[DST results summary combined all methods]

Others:
LPA DST CBNAAT Total H+R Total H+R Total H Total R Only R Res by In Neg,
processed test done Sens Res only Res only Res CBNAAT Process Conta,
NTM

Denominator (No.) Percent

Specificity (%) LPA Second line Sensitivity (%)

Ofloxacilin
Kanamycin

:
Solid Liquid Others:
Total Total PZA and
second line second line Total O Total K Total In Neg,
O+K O+K other
DST DST only Res only Res XDR Process Conta,
Sen Res drugs
Processed Processed NTM

Specificity (%)
 Total no of Total no of
MDR out of XDR out of
EP-TB EP-TB
Totat no of processed processed
EP-TB
sample
processed